Immatics N.V

IMTX NASDAQ Santé & Biotech Europe NL0015285941
10.01 $
0.25 %

Immatics N.V se spécialise dans la recherche et le développement de thérapies T-cellulaires pour le traitement du cancer.

Performance & Momentum

6 Months 11.60 %
1 Year 110.48 %
3 Years 17.32 %
5 Years 1.96 %

Similar stocks to Immatics N.V

Anantys Community

Be the first to share your analysis on Immatics N.V.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases